CATHERINE LYKINS: Open Payments
NPI 1619386968 · CUMMING, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,283 in 104 payments from 31 companies in 2025. Trend: 2023 $2,057 · 2024 $2,342 · 2025 $2,283
Food & beverage: $2,222Education: $61
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 17 | $301 |
| UCB, Inc. | 11 | $235 |
| ABBVIE INC. | 20 | $228 |
| Janssen Biotech, Inc. | 7 | $191 |
| SK Life Science, Inc. | 4 | $137 |
| ARGENX US, INC. | 4 | $115 |
| Neurocrine BioSciences, Inc. | 3 | $96 |
| Biogen, Inc. | 3 | $90 |
| Novartis Pharmaceuticals Corporation | 3 | $86 |
| Amgen Inc. | 2 | $79 |
Products named: NURTEC ODT, UBRELVY, INGREZZA, PANZYGA, KESIMPTA, Nayzilam, Zilbrysq, Briviact.
Industry payments across GA — which companies pay providers there.
